BEHANDLUNG VON SYNUKLEINOPATHIEN

European patent · EP4112053 · In force

Register entry

Publication number
EP4112053
Application number
EP22175032
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 10, 2017
Published
Jan 4, 2023
Granted
Feb 14, 2024
Protection ends at the latest
Oct 9, 2037
Next annual fee due
Oct 31, 2026
IPC classes
A61K 31/4375 (2006.01)
A61K 31/519 (2006.01)
A61K 31/713 (2006.01)
C12N 15/113 (2010.01)
A61P 25/28 (2006.01)
A61P 25/16 (2006.01)
Priority
EP 16193362 11.10.2016
Divided from
EP17787904
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Dec 25, 2024

    Change

    Published in Swissreg on 25.12.2024

  3. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  4. May 14, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 14.05.2024

  5. Feb 14, 2024

    Granted

    Published in Swissreg on 14.02.2024

Parties

Holder

Klinikum rechts der Isar der Technischen Universität München

Ismaninger Straße 22, 81675 München, DE

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

Venusberg-Campus 1, Gebäude 99, 53127 Bonn, DE

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

Höllerhage, Matthias

80687 München, DE

Höglinger, Günter

82152 Planegg, DE

Rösler, Thomas Werner

81241 München, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.